Clinical research progress of esketamine in perioperative neuroprotection: from mechanisms to therapeutic neuroprotection
Hua Wang, Ce Zhou, YingDong Qu, Hao Luo · 2026
Read Clinical research progress of esketamine in perioperative neuroprotection: from mechanisms to therapeutic neuroprotection by Hua Wang, Ce Zhou, YingDong Qu, Hao Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13630739.txt.
Description
Hua Wang and co-authors review clinical research on esketamine for protecting the brain around the time of surgery, in a 2026 paper. Surgery brings risks such as reduced blood flow, brain inflammation, and cognitive problems. These drive poor recovery, disability, and death around operations.
Esketamine is one mirror form of ketamine. It blocks a key brain receptor and also shows anti-inflammatory, anti-death, and antioxidant traits. Compared with mixed ketamine, it is stronger, faster, gentler on breathing, and causes fewer psychiatric effects. The review covers its protective mechanisms and clinical uses, and points to future research for better surgical outcomes.
Catalog record
| CREATOR | Hua Wang, Ce Zhou, YingDong Qu, Hao Luo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |